Centennial Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$389K Hold
423
0.14% 110
2025
Q4
$455K Hold
423
0.18% 99
2025
Q3
$323K Hold
423
0.13% 116
2025
Q2
$330K Sell
423
-132
-24% -$103K 0.14% 111
2025
Q1
$458K Buy
555
+71
+15% +$59.1K 0.22% 90
2024
Q4
$374K Hold
484
0.18% 101
2024
Q3
$429K Hold
484
0.2% 94
2024
Q2
$438K Hold
484
0.21% 86
2024
Q1
$377K Hold
484
0.19% 97
2023
Q4
$282K Sell
484
-86
-15% -$50.2K 0.17% 100
2023
Q3
$306K Hold
570
0.21% 94
2023
Q2
$267K Hold
570
0.18% 105
2023
Q1
$196K Hold
570
0.13% 128
2022
Q4
$209K Buy
+570
New +$202K 0.12% 131

Other funds holding LLY

Centennial Bank's LLY Position: Q1 2026 in Review

Centennial Bank held its Eli Lilly (LLY) position steady in Q1 2026 at 423 shares worth $389K. The position accounts for 0.14% of the portfolio, ranked #110.

Centennial Bank first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $458K in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Centennial Bank held 423 shares of Eli Lilly worth $389K as of Q1 2026.
  • Centennial Bank left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.14% of Centennial Bank's portfolio in Q1 2026, its #110 holding.
  • Centennial Bank first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Centennial Bank's Eli Lilly position peaked at $458K in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Centennial Bank's 13F filing for Q1 2026, filed 6 May 2026.